Brandon Orr‐Walker

1.5k total citations
43 papers, 1.1k citations indexed

About

Brandon Orr‐Walker is a scholar working on Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine and Nephrology. According to data from OpenAlex, Brandon Orr‐Walker has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Orthopedics and Sports Medicine and 9 papers in Nephrology. Recurrent topics in Brandon Orr‐Walker's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Bone health and osteoporosis research (10 papers) and Diabetes Management and Research (9 papers). Brandon Orr‐Walker is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Bone health and osteoporosis research (10 papers) and Diabetes Management and Research (9 papers). Brandon Orr‐Walker collaborates with scholars based in New Zealand, Australia and United Kingdom. Brandon Orr‐Walker's co-authors include Ian R. Reid, Margaret C. Evans, Anne Horne, Ruth Ames, Judith Clearwater, Gregory D. Gamble, Greg Gamble, Fiona Wu, Barbara Mason and M. A. F. Murray and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Brandon Orr‐Walker

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandon Orr‐Walker New Zealand 18 311 303 244 242 161 43 1.1k
Anna Challa Greece 22 174 0.6× 149 0.5× 440 1.8× 207 0.9× 152 0.9× 79 1.4k
Ruban Dhaliwal United States 21 98 0.3× 514 1.7× 405 1.7× 233 1.0× 96 0.6× 44 1.1k
Victória Zeghbi Cochenski Borba Brazil 22 113 0.4× 339 1.1× 470 1.9× 171 0.7× 114 0.7× 66 1.5k
J.J. Villafruela Spain 17 240 0.8× 95 0.3× 253 1.0× 80 0.3× 201 1.2× 53 987
Fiona Wu New Zealand 14 53 0.2× 285 0.9× 173 0.7× 141 0.6× 125 0.8× 23 733
Chan‐Hee Jo United States 17 742 2.4× 92 0.3× 150 0.6× 87 0.4× 172 1.1× 44 1.5k
Mehdi Rambod United States 17 735 2.4× 96 0.3× 85 0.3× 180 0.7× 88 0.5× 35 1.3k
Angel de Francisco Spain 15 610 2.0× 43 0.1× 137 0.6× 225 0.9× 92 0.6× 19 1.7k
Liesbeth Viaene Belgium 20 907 2.9× 179 0.6× 169 0.7× 72 0.3× 27 0.2× 29 1.4k
Bent Lind Denmark 21 41 0.1× 165 0.5× 374 1.5× 238 1.0× 109 0.7× 78 1.8k

Countries citing papers authored by Brandon Orr‐Walker

Since Specialization
Citations

This map shows the geographic impact of Brandon Orr‐Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Orr‐Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Orr‐Walker more than expected).

Fields of papers citing papers by Brandon Orr‐Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Orr‐Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Orr‐Walker. The network helps show where Brandon Orr‐Walker may publish in the future.

Co-authorship network of co-authors of Brandon Orr‐Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Orr‐Walker. A scholar is included among the top collaborators of Brandon Orr‐Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Orr‐Walker. Brandon Orr‐Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Dahai, Uchechukwu Levi Osuagwu, John E. Baker, et al.. (2023). Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years. Journal of the American Heart Association. 12(18). e030159–e030159. 2 indexed citations
3.
4.
Yu, Dahai, Uchechukwu Levi Osuagwu, John Baker, et al.. (2023). Adverse Clinical Outcomes Attributable to Socioeconomic and Ethnic Disparities Among People with Type 2 Diabetes in New Zealand Between 1994–2018: A Multiple Linked Cohort Study. Clinical Epidemiology. Volume 15. 511–523. 3 indexed citations
5.
Yu, Dahai, Uchechukwu Levi Osuagwu, John E. Baker, et al.. (2023). Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysis. Cardiovascular Diabetology. 22(1). 163–163. 2 indexed citations
6.
Pylypchuk, Romana, Sue Wells, Andrew Kerr, et al.. (2021). Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study. The Lancet. 397(10291). 2264–2274. 33 indexed citations
7.
8.
Coppell, Kirsten J., Rosemary M. Hall, Michelle Downie, et al.. (2020). Diabetes and COVID-19-the meeting of two pandemics: what are the concerns?. PubMed. 133(1514). 85–87. 3 indexed citations
9.
Lee, Jessica H. & Brandon Orr‐Walker. (2020). Diabetic ketoacidosis admissions at Middlemore Hospital: observational study of cause and patient demographics.. New Zealand medical journal. 133(1525). 34–40. 2 indexed citations
10.
Wu, Ted, Michelle Downie, Manish Khanolkar, et al.. (2015). Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes. Diabetes Therapy. 6(3). 273–287. 23 indexed citations
11.
Chan, Wing C., Gary Jackson, Craig Wright, et al.. (2014). The future of population registers: linking routine health datasets to assess a population's current glycaemic status for quality improvement. BMJ Open. 4(4). e003975–e003975. 11 indexed citations
12.
Dalbeth, Nicola, et al.. (2013). Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study. Annals of the Rheumatic Diseases. 73(5). 797–802. 66 indexed citations
13.
Braatvedt, G. D., Tim Cundy, Michael Crooke, et al.. (2012). Understanding the new HbA1c units for the diagnosis of Type 2 diabetes.. PubMed. 125(1362). 70–80. 36 indexed citations
14.
Reid, Ian R., Tim Cundy, Andrew Grey, et al.. (2007). Addition of Monofluorophosphate to Estrogen Therapy in Postmenopausal Osteoporosis: A Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 92(7). 2446–2452. 16 indexed citations
15.
Bolland, Mark J, Ruth Ames, Anne Horne, et al.. (2006). The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporosis International. 18(4). 479–486. 90 indexed citations
16.
Orr‐Walker, Brandon, Margaret C. Evans, Ian R. Reid, & Tim Cundy. (2005). Increased abdominal fat in young women of Indian origin.. PubMed. 14(1). 69–73. 7 indexed citations
17.
Orr‐Walker, Brandon, Margaret C. Evans, Judith Clearwater, et al.. (2000). Effects of Hormone Replacement Therapy on Bone Mineral Density in Postmenopausal Women With Primary Hyperparathyroidism. Archives of Internal Medicine. 160(14). 2161–2161. 61 indexed citations
18.
Reid, Ian R., Ruth Ames, Brandon Orr‐Walker, et al.. (2000). Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. The American Journal of Medicine. 109(5). 362–370. 137 indexed citations
19.
Orr‐Walker, Brandon, Margaret C. Evans, Ruth Ames, et al.. (1998). The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post‐menopausal women. Clinical Endocrinology. 49(5). 615–618. 64 indexed citations
20.
Orr‐Walker, Brandon, D. Wattie, Margaret C. Evans, & Ian R. Reid. (1997). Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post‐menopausal osteoporosis. Clinical Endocrinology. 46(1). 87–92. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Challa Breakdown of academic impact, for papers by Ruban Dhaliwal Breakdown of academic impact, for papers by Victória Zeghbi Cochenski Borba Breakdown of academic impact, for papers by J.J. Villafruela Breakdown of academic impact, for papers by Fiona Wu Breakdown of academic impact, for papers by Chan‐Hee Jo Breakdown of academic impact, for papers by Mehdi Rambod Breakdown of academic impact, for papers by Angel de Francisco Breakdown of academic impact, for papers by Liesbeth Viaene Breakdown of academic impact, for papers by Bent Lind
Rankless by CCL
2026